About Trichem Pharmascience
Trichem Pharmascience is a Healthcare company based in Mumbai (India) founded in 1998, and was acquired by IMCD in June 2025. Specialty chemicals and intermediates are supplied to pharmaceutical manufacturers. Trichem Pharmascience offers products and services including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity in India is Trichem Pharmascience LLP (ABC-1474). Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Trichem Pharmascience LLP was founded in 1998 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where specialty chemicals and intermediates are manufactured for various industries. Expertise is held in facility maintenance products and coatings, with applications in high-heat and high-pressure environments. A presence is maintained across India, ensuring products and services meet industry standards.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Website tricheminc.net
- Social LinkedIn
- Acquired by IMCD (Jun 2025)
- Legal Name Trichem Pharmascience Llp
- Date of Incorporation 20 Aug, 2022
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Trichem Pharmascience
Trichem Pharmascience is associated with 4 registered companies on The Company Check; the primary company is Pharmadose Generics Llp. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharmadose Generics Llp CIN ABC-1474 | Active | 20 Aug 2022 | Mumbai, Maharashtra | 2 | View details | ||
| Trichem Healthcare Private Limited CIN U24230MH2004PTC149368 | Active | 03 Nov 2004 | Mumbai, Maharashtra | ₹21.7 Cr | 2 | View details | |
| Trichem Lifesciences Limited CIN U24230MH2004PLC146573 | Active | 27 May 2004 | Mumbai, Maharashtra | ₹9.7 Cr | 3 | View details | |
| Trichem Intermediates Private Limited CIN U24100GJ2007PTC050520 | Active | 12 Apr 2007 | Ahmedabad, Gujarat | ₹14.2 Cr | 2 | View details |
Products & Services of Trichem Pharmascience
Trichem Pharmascience offers a comprehensive portfolio of products and services, including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.
Antibiotic API used in pharmaceutical formulations.
Chemotherapy API for cancer treatment applications.
Anticancer API for medical and therapeutic use.
Antibiotic and chemotherapy API for oncology.
Investors in Trichem Pharmascience
Trichem Pharmascience has secured backing from 1 investor. Prominent investors backing the company include IMCD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Speciality chemicals and food ingredients are distributed by IMCD. | 1995 | imcdgroup.com | Rotterdam, Netherlands |
Investor details for Trichem Pharmascience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Pharmadose Generics Llp (Trichem Pharmascience)
Pharmadose Generics Llp is the primary company behind Trichem Pharmascience. The boards of the 4 registered companies of Trichem Pharmascience currently have 7 directors; the longest-serving is Manojkumar Sampatmal Kucheria, appointed in 2007. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manojkumar Sampatmal Kucheria DIN 01423828 | Director | 12 Apr 2007 | 19 yrs 7 mo | Trichem Intermediates Private Limited |
| Abhishek Manoj Kucheria DIN 07551019 | Director | 05 Nov 2018 | 8 yrs | Trichem Intermediates Private Limited |
| Heena Chetan Jain DIN 09689277 | Designated Partner | 20 Aug 2022 | 4 yrs 3 mo | Pharmadose Generics Llp |
| Chetan Ramesh Jain DIN 00217531 | Designated Partner | 20 Aug 2022 | 4 yrs 3 mo | Pharmadose Generics Llp |
| Ramanuj Chandrashekhar Kankani DIN 08274950 | Director | 26 Jun 2025 | 1 yr 4 mo | Trichem Healthcare Private Limited, Trichem Lifesciences Limited |
| Narendra Sujit Varde DIN 09026419 | Director | 26 Jun 2025 | 1 yr 4 mo | Trichem Healthcare Private Limited, Trichem Lifesciences Limited |
| Palak Vij DIN 11201756 | Additional Director | 18 Jul 2025 | 1 yr 4 mo | Trichem Lifesciences Limited |
Timeline of Trichem Pharmascience
2 dated milestones of Trichem Pharmascience across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Trichem Pharmascience is founded.
- Exit Acquired by IMCD.
Competitors of Trichem Pharmascience
Trichem Pharmascience has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of Trichem Pharmascience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Trichem Pharmascience
The website of Trichem Pharmascience (tricheminc.net) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 43.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Trichem Pharmascience (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trichem Pharmascience
Trichem Pharmascience was founded in 1998.
Trichem Pharmascience is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Trichem Pharmascience LLP was founded in 1998 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where specialty chemicals and intermediates are manufactured for various industries. Expertise is held in facility maintenance products and coatings, with applications in high-heat and high-pressure environments. A presence is maintained across India, ensuring products and services meet industry standards.
Trichem Pharmascience's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Trichem Pharmascience offers Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.
Trichem Pharmascience has 1 investor. Key investors include IMCD.
Trichem Pharmascience is associated with 4 legal entities: Pharmadose Generics Llp, Trichem Intermediates Private Limited, Trichem Healthcare Private Limited and others.
Yes. Trichem Pharmascience was acquired by IMCD in June 2025.
The legal entities of Trichem Pharmascience currently have 7 directors, including Heena Chetan Jain, Chetan Ramesh Jain, Manojkumar Sampatmal Kucheria and others.
